Literature DB >> 23831048

Patients benefit from low-pressure settings enabled by gravitational valves in normal pressure hydrocephalus.

Florian Baptist Freimann1, Peter Vajkoczy, Christian Sprung.   

Abstract

OBJECTIVE: The ability of siphon regulatory devices to improve overdrainage control despite low-pressure settings of the valve for the horizontal body position has been described previously. We aim to provide a systematic investigation on the ability of gravitational units as siphon regulatory devices to improve clinical outcome in shunt therapy.
METHODS: We analyzed retrospectively postoperative complications, type and frequency of valve adjustments and the clinical outcome using Black's outcome scale at different time points of all iNPH patients operated in our center between January 2007 and December 2010. They had received either a proGAV® valve with an integrated gravitational unit, or a programmable Codman Hakim® valve without an integrated siphon regulatory device.
RESULTS: The postoperative course of 55 proGAV® and 45 programmable Codman Hakim® patients was analyzed. The latest documented valve setting of the proGAV® group and Codman Hakim® group was median 50mm H2O and 120 mm H2O, respectively. Overdrainage occurred among both groups in 20% of the patients, while surgical intervention for overdrainage-related complications was seen to be necessary only in 7% of the cases in the Codman Hakim® group. Clinical outcome differed in an increasing manner over the observation period (median 4 points after 3, 12 months and at final presentation in the proGAV®; median 4 points after 3 and 12 months and 3 points at final presentation in Codman Hakim® group (p=0.001)).
CONCLUSION: Adjustable and gravity-assisted valves like the proGAV® improve overdrainage control and enable thus low-pressure settings for the horizontal body position. We observed an improved and more sustainable functional outcome for iNPH patients with an adjustable and gravity-assisted valve compared to iNPH patients without an integrated siphon regulatory device.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Functional underdrainage; Gravitational valves; Normal pressure hydrocephalus; Ventriculoperitoneal shunt

Mesh:

Year:  2013        PMID: 23831048     DOI: 10.1016/j.clineuro.2013.06.010

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Feasibility of telemetric ICP-guided valve adjustments for complex shunt therapy.

Authors:  Florian Baptist Freimann; Matthias Schulz; Hannes Haberl; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2013-11-22       Impact factor: 1.475

2.  Outcome of ventriculoperitoneal shunt and predictors of shunt revision in infants with posthemorrhagic hydrocephalus.

Authors:  Shyamal C Bir; Subhas Konar; Tanmoy Kumar Maiti; Piyush Kalakoti; Papireddy Bollam; Anil Nanda
Journal:  Childs Nerv Syst       Date:  2016-06-09       Impact factor: 1.475

3.  Ventriculoperitoneal shunt complications in an adult population: A comparison of various shunt designs to prevent overdrainage.

Authors:  Virendra Rajendrakumar Desai; Saeed Sam Sadrameli; Amanda V Jenson; Samuel K Asante; Bradley Daniels; Todd W Trask; Gavin Britz
Journal:  Surg Neurol Int       Date:  2020-09-05

Review 4.  Antisiphon device: A review of existing mechanisms and clinical applications to prevent overdrainage in shunted hydrocephalic patients.

Authors:  An-Ping Huang; Lu-Ting Kuo; Dar-Ming Lai; Shih-Hung Yang; Meng-Fai Kuo
Journal:  Biomed J       Date:  2021-08-17       Impact factor: 7.892

5.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.